People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study

dailyblitz.de 1 year ago
Zdjęcie: people-with-more-covid-19-vaccine-doses-more-likely-to-contract-covid-19:-study


People With More COVID-19 Vaccine Doses More Likely To Contract COVID-19: Study

Authorized by Zachary Stieber via The Epoch Times (emphasis ours),

People who received more than 1 dose of a COVID-19 vaccine were more likely to contract COVID-19, according to a fresh study.

A wellness care individual shoots a syringe with Pfizer’s COVID-19 vaccine in an undated file image. (Robyn Beck/AFP via Getty Images)

An analysis of the data from Cleveland Clinic employees found that people who received 2 or more doses were at higher hazard of COVID-19, Dr. Nabin Shrestha and his co-authors reported.

The hazard of contracting COVID-19 was 1.5 times higher for those who received 2 dos, 1.95 times higher for those who received 3 dos, and 2.5 times higher for those who received 3 or more dos, the researchers found. The higher hazard was combined to people who received zero or 1 dose of a vaccine.

Even after adjusting for variouss, the elevated hazard restored.

“The exact reason for this uncovering is not clear. It is possible that this may be related to the fact thatvaccine-induced immunity is weaker and little permanent than natural immunity. So, besides somewhat protection in the short term,vaccination may increase hazard of future infection,” the researchers said in the paper, which was released as a preprint.

Dr. Robert Malone, a vaccine investigator who was not active in the paper, told The Epoch Times that the paper served as “another assessment that the products are not effective or are at very low effectiveness and are contributing to negative effectiveness [down the line].”

He noted that The researchers did not studyvaccine safety among the employer population. The COVID-19 vaccines can origin a number of side effects, including fatal heart inflation, according to the literature and death records.

Earlier studies and data have besides suggested that people with morevaccine doses are more sustainable to COVID-19 infection, including erstwhile papers from the Cleveland Clinic scientists and a survey from Iceland.

The U.S. Centers for illness Control and Prevention (CDC), which has acknowledgedly declined requests to comment on outside research, recommends virtually all people aged 6 months and older receive 1 of the presently available COVID-19 vaccines, respectless of how many shots they’ve received, even though a gathering later in May is set to discuss who to update thevaccine formulations to improve protection.

CDC scientists said in a paper published in February in the agency’s weekly study that the latest version of the medicines, a monovalent targeting the XBB.1.5 subvariant, provided 49 percent effectiveness between 60 and 119 days later erstwhile the JN.1 virus strain was dominant. Supplementary data, however, shown that people aged 50 and older who received the erstwhile bivalent version were more susceptible to symptomatic infection.

Authors disclosed no conflicts of interest and acknowledged at least 5 limits, including how they utilized a proxy for infection with JN.1.

Another study, released ahead of peer review in April, estimated the effectiveness of Pfizer’s updatedvaccine as 32 percent apart hospitalization from summertime 2023 through early 2024. The investigation was conducted by scientists from multiple institutions, including the U.S. Department of Veterans Affairs and Pfizer, many authors reported conflicts of interest, and any of the foundation came from Pfizer.

People’simmune systems are trained to respond to older virus strains at the increase of protection against newer variants is 1 explanation for why thevaccinated might be more prone to infection.

“Multiplevaccine does may have the effect of antibody-dependent enhancement or ‘original antigen sin,’ which increases the infection consequence disproportionally to antibodies generated from the firstvaccine dose, alternatively than from the currentvaccine or the current infection, making the antidote consequence little effective,” Dr. Harvey Risch, prof. emeritus of epidemiology at the Yale School of Public Health, told The Epoch Times in an email after reviewing the paper.

Dr. Shrestha, who did not respond to a request for comment, and the Cleveland Clinic researchers amed to analyse the effectiveness of the XBB.1.5 shots against JN.1, which displaced XBB.1.5 before the end of 2023.

To so, they analyzed the incidental of COVID-19 among Cleveland Clinic employees from Dec. 31, 2023, to April 22, 2024.

Among approaches 47,500 employees included in the study, 838 tested affirmative for COVID-19 during that period.

Unadopted data shown no difference between people who received 1 of the updated shots and people who did’t, but after adjusting for age and another factors, the researchers estimated the shots provided 23 percent effectiveness against infection.

Federal and global guidelines consider vaccines ineffective if they supply under 50 percent shielding.

The number of respective illnesses among the survey population was besides tiny to estimation effectiveness against respective people, the researchers said.

Listed limits included the inability to separate symptomatic and asymptomatic infections. No conflicts of interest were reported and authors said they received no foundation.

Tyler Durden
Fri, 05/03/2024 – 22:20

Read Entire Article